Judith Bovee
Judith Bovee
Professor of Pathology, LUMC
Verified email at lumc.nl
Cited by
Cited by
The clinical approach towards chondrosarcoma
H Gelderblom, PCW Hogendoorn, SD Dijkstra, CS Van Rijswijk, AD Krol, ...
The oncologist 13 (3), 320-329, 2008
Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up
PG Casali, L Jost, P Reichardt, M Schlemmer, JY Blay
Annals of Oncology 20, iv64-iv67, 2009
Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome
TC Pansuriya, R Van Eijk, P d'Adamo, MAJH Van Ruler, ML Kuijjer, ...
Nature genetics 43 (12), 1256-1261, 2011
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ...
Annals of Oncology 29, iv51-iv67, 2018
Multiple osteochondromas
JVMG Bovée
Orphanet journal of rare diseases 3 (1), 1-7, 2008
Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA
VL Luks, N Kamitaki, MP Vivero, W Uller, R Rab, JVMG Bovée, KL Rialon, ...
The Journal of pediatrics 166 (4), 1048-1054. e5, 2015
Cartilage tumours and bone development: molecular pathology and possible therapeutic targets
JVMG Bovée, PCW Hogendoorn, JS Wunder, BA Alman
Nature Reviews Cancer 10 (7), 481-488, 2010
Identification of a novel, recurrent HEY1‐NCOA2 fusion in mesenchymal chondrosarcoma based on a genome‐wide screen of exon‐level expression data
L Wang, T Motoi, R Khanin, A Olshen, F Mertens, J Bridge, PD Cin, ...
Genes, Chromosomes and Cancer 51 (2), 127-139, 2012
Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment
JVMG Bovée, AM Cleton-Jansen, AHM Taminiau, PCW Hogendoorn
The lancet oncology 6 (8), 599-607, 2005
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas
JVMG Bovée, AM Cleton-Jansen, W Wuyts, G Caethoven, AHM Taminiau, ...
The American Journal of Human Genetics 65 (3), 689-698, 1999
Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array
RC Slieker, SD Bos, JJ Goeman, JVMG Bovée, RP Talens, ...
Epigenetics & chromatin 6 (1), 1-12, 2013
The clinical approach toward giant cell tumor of bone
L van der Heijden, PDS Dijkstra, MAJ van de Sande, JR Kroep, RA Nout, ...
The oncologist 19 (5), 550, 2014
Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas
J Zedenius, C Larsson, U Bergholm, J Bovee, A Svensson, B Hallengren, ...
The Journal of Clinical Endocrinology & Metabolism 80 (10), 3088-3090, 1995
Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors
D Eefting, YM Schrage, MJA Geirnaerdt, S Le Cessie, AHM Taminiau, ...
The American journal of surgical pathology 33 (1), 50-57, 2009
Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma
JVMG Bovée, LJCM van den Broek, AM Cleton-Jansen, ...
Laboratory investigation 80 (12), 1925-1933, 2000
Enchondromatosis: insights on the different subtypes
TC Pansuriya, HM Kroon, JVMG Bovée
International journal of clinical and experimental pathology 3 (6), 557, 2010
Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential: a report of 35 cases and a review of the literature
JVMG Bovée, RO van der Heul, AHM Taminiau, PCW Hogendoorn
Cancer: Interdisciplinary International Journal of the American Cancer …, 1999
Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients
SHM Verdegaal, JVMG Bovée, TC Pansuriya, RJ Grimer, H Ozger, ...
The oncologist 16 (12), 1771, 2011
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study
C Colombo, R Miceli, AJ Lazar, F Perrone, RE Pollock, A Le Cesne, ...
Cancer 119 (20), 3696-3702, 2013
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, ...
Annals of Oncology 29, iv79-iv95, 2018
The system can't perform the operation now. Try again later.
Articles 1–20